Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily G McDonald

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 2, 2022
Benefits of nirmatrelvir-ritonavir remain unproven for some populationsEmily G McDonald, Todd Lee
Annual Review of Medicine|September 20, 2023
Polypharmacy and Deprescribing in Older AdultsWade Thompson, Emily G McDonald
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 30, 2016
Extracorporeal membrane oxygenation for the treatment of severe refractory hantavirus cardiopulmonary syndromeHan Yao, Emily G McDonald
JAMA Internal Medicine|August 18, 2020
Deprescribing Proton Pump Inhibitors-ReplyEmily G McDonald, Todd C Lee
JAMA Internal Medicine|December 6, 2016
Costs of Inpatient Medications: Do Dispensing and Nursing Fees Lead to Overestimates?-ReplyEmily G McDonald, Todd C Lee
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Nirmatrelvir-ritonavir for COVID-19Emily G McDonald, Todd C Lee
JAMA|June 17, 2015
Clinician Understanding of Cholesterol Treatment GuidelinesTodd C Lee, Emily G McDonald
The New England Journal of Medicine|September 30, 2016
Preventing Catheter-Associated Urinary Tract InfectionsTodd C Lee, Emily G McDonald
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2022
Remdesivir for the treatment of COVID-19: author's responseTodd C Lee, Emily G McDonald
JAMA Internal Medicine|February 25, 2020
Deprescribing Proton Pump Inhibitors: Overcoming ResistanceTodd C Lee, Emily G McDonald
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 2, 2022
Benefits of nirmatrelvir-ritonavir remain unproven for some populationsEmily G McDonald, Todd Lee
Annual Review of Medicine|September 20, 2023
Polypharmacy and Deprescribing in Older AdultsWade Thompson, Emily G McDonald
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 30, 2016
Extracorporeal membrane oxygenation for the treatment of severe refractory hantavirus cardiopulmonary syndromeHan Yao, Emily G McDonald
JAMA Internal Medicine|August 18, 2020
Deprescribing Proton Pump Inhibitors-ReplyEmily G McDonald, Todd C Lee
JAMA Internal Medicine|December 6, 2016
Costs of Inpatient Medications: Do Dispensing and Nursing Fees Lead to Overestimates?-ReplyEmily G McDonald, Todd C Lee
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Nirmatrelvir-ritonavir for COVID-19Emily G McDonald, Todd C Lee
JAMA|June 17, 2015
Clinician Understanding of Cholesterol Treatment GuidelinesTodd C Lee, Emily G McDonald
The New England Journal of Medicine|September 30, 2016
Preventing Catheter-Associated Urinary Tract InfectionsTodd C Lee, Emily G McDonald
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2022
Remdesivir for the treatment of COVID-19: author's responseTodd C Lee, Emily G McDonald
JAMA Internal Medicine|February 25, 2020
Deprescribing Proton Pump Inhibitors: Overcoming ResistanceTodd C Lee, Emily G McDonald
Pageof 21